How Does FidoCure Work?

FidoCure is pioneering a revolutionary approach to treating canine cancer - bringing the power of precision medicine from human oncology to veterinary care. As the first and only service of its kind, FidoCure provides genomic testing to identify the unique genetic markers driving each dog's cancer. This information can guide individualized treatment plans and leverage cutting-edge targeted therapies and innovative medicines precisely matched to a patient's disease profile. Genomic sequencing can also provide valuable insights into diagnosis and prognosis, offering a more comprehensive understanding of the patient's condition.

How FidoCure Works

The process begins when a veterinarian submits a dog's tumor sample for histopathology and diagnosis, a standard procedure. Once a malignancy is confirmed, the veterinarian can enroll in FidoCure, and tissue samples from the same biopsy are sent to FidoCure's labs. Using advanced next-generation sequencing (NGS), FidoCure's specialists analyze the genomic makeup of the cancer cells, pinpointing key mutations, biomarkers, and therapeutic targets.

Within 2-3 weeks, veterinarians receive a comprehensive genomic report detailing the dog's unique cancer profile. This report, prepared by FidoCure's specialized team of scientists and veterinary oncologists, provides clear, actionable insights. It identifies which cancer drugs or therapies may be most effective based on the dog's specific mutations and highlights opportunities for emerging treatments. The report also serves as a roadmap for therapy selection, offering prognostic information on the cancer's aggressiveness and potential evolution. This information guides a proactive, precision treatment approach tailored to the dog's individual needs.

If the veterinarian determines one of the suggested precision therapies is appropriate, FidoCure facilitates access through a network of specialized compounding pharmacies. The cost varies based on the specific drug or combination of drugs needed for the dog's treatment.

A Rapidly Expanding Network

FidoCure currently partners with veterinary clinics across 32 U.S. states and is rapidly expanding nationwide. While many major pet insurance plans cover FidoCure's genomic testing services, coverage details should be verified with the provider. Additionally, while FidoCure bills veterinarians directly via a pay-per-drug order, the total cost to pet owners can vary based on each clinic's pricing for diagnostics, treatment, and associated care.

Treating All Cancers with Precision

FidoCure's precision oncology platform applies to all types of canine cancer. While the most common cases treated have included hemangiosarcoma and transitional cell carcinoma (TCC), FidoCure also has significant experience with rare cancers like histiocytic sarcoma. Notably, around half of all cases referred to FidoCure involve dogs whose cancer did not respond to standard therapies, highlighting the potential of precision medicine to identify new treatment options.

To decode each patient's cancer and develop individualized treatment strategies, FidoCure leverages a powerful array of cutting-edge technologies. Next-generation sequencing provides fast and accurate DNA testing of tumor samples, while Artificial Intelligence (AI) and Machine Learning (ML) systems integrate vast genomic data to drive research insights.

These technologies converge to enable breakthrough therapeutic approaches precisely tailored to each dog. Targeted therapy harnesses drugs designed to inhibit or activate specific genes and proteins altered in a patient's cancer cells. Additionally, combination therapy enhances treatment efficacy by combining multiple approaches to combat cancer.

A Tailored, Data-Driven Approach

Pet owners never want to leave any stone unturned in battling their dog's cancer. By providing access to advanced genomic intelligence and innovative precision treatments, FidoCure empowers pet owners to make truly data-driven decisions rooted in the molecular reality of their dog's disease.

For veterinarians, FidoCure's platform equips them with powerful new tools in their fight against cancer. Reliable genomic insights, therapeutic decision support, and access to cutting-edge medicines allow vets to elevate their clinical expertise and offer patients the latest, most personalized care.

While still an emerging field in veterinary medicine, cases with FidoCure demonstrate the incredible potential of precision oncology. As the genomic library grows and understanding deepens, more dogs than ever before can live long and happy lives from this individualized approach to cancer care.

For canine companions battling cancer, discussing with a veterinarian whether working with FidoCure is the right next step may be beneficial. Precision medicine is an effective strategy, and FidoCure believes every dog deserves a personalized, advanced strategy in the fight against cancer.